DRI Healthcare Acquisitions LP
Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Healthcare, Biotechnology, Pharmaceuticals
Stage Focus
Growth, Late Stage, Pre-IPO
Geographical Focus
United States, Canada, Hong Kong, Japan, Australia, Europe, Asia, Singapore, China, India, Indonesia, South Korea, Middle East, Vietnam, Malaysia, New Zealand, Philippines, Thailand, Taiwan, Africa, South America
Industries Focus
- Healthcare
- Healthcare Services
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Medical Research
- Clinical Trials
- Regenerative Medicine
- Immunotherapy
- Oncology
- Neurology
- Consumer Health
- Health IT
Investment Size:
5,000,000 to 500,000,000 USD
Investor Details
DRI Healthcare Acquisitions LP is a private investment firm specializing in healthcare royalty monetization and financing. The firm focuses on acquiring dependable, patent-protected cash flow streams derived from the sales of important drugs across multiple therapeutic areas. By providing capital to biopharmaceutical innovators, DRI Healthcare builds a diversified portfolio of interests in medicines that effectively treat and address unmet medical needs.
The firm's investment strategy centers on medicines that matter, pursuing deals for long-duration patent-protected assets that provide significant clinical benefits. DRI Healthcare offers investors the opportunity to leverage its proven experience in selecting and acquiring high-quality biopharma products, participating in the growth trends of life sciences while limiting the risks and costs associated with drug development.
DRI Healthcare's portfolio includes investments in various therapeutic areas, such as oncology, neurology, and ophthalmology. The firm has engaged in multiple royalty monetization transactions, including agreements with companies like Omeros Corporation and Radius Pharmaceuticals. These strategic investments aim to generate attractive returns and significant growth potential for investors, while supporting the advancement of innovative healthcare solutions.
Requirements
- High-quality, patent-protected assets
- Medically necessary therapeutics
- Market-leading products
- Strong intellectual property protection
- Leading marketers
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[Email Hidden]
Portfolio Companies
- Omeros Corporation
- Radius Pharmaceuticals
- Viridian Therapeutics
- KalVista Pharmaceuticals
Mentioned In
Claim this Investor
Are you an official representative of DRI Healthcare Acquisitions LP?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim